25Jan 2024
Multimorbidity impacts cardiovascular disease risk following percutaneous coronary intervention

Multimorbidity impacts cardiovascular disease risk following percutaneous coronary intervention

The study involved 14,025 patients undergoing their initial percutaneous coronary intervention (PCI) exhibited multimorbidity, with hypertension (59%) and dyslipidaemia (60%) being prevalent. Clusters with distinctive multimorbidity patterns were identified, correlating with varying risks of 30-day and 12-month major adverse cardiac and cerebrovascular events (MACCE) post-PCI. Specific clusters demonstrated significantly higher risks, emphasizing the need for personalized treatment approaches to improve patient outcomes and quality of care.

  • #cardiology

Like

Save

Share